Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Acta Neuropathol. 2021 Mar 7;141(5):651–666. doi: 10.1007/s00401-021-02279-2

Table 4:

Proportions (mean, sd) of each Rhes phenotype with PHF-1+ tau inclusions by region.

Diffuse Rhes Punctiform Rhes Absent Rhes
Dx PHF-1+ PHF-1− PHF-1+ PHF-1− PHF-1+ PHF-1− p-valuea
a) Entorhinal cortex Total (n=30) 0.043, 0.073 0.957, 0.073 0.726, 0.323 0.274, 0.323 0.919, 0.188 0.081, 0.188 < 0.0001b
HC (n=5) 0.01, 0.011 0.99, 0.011 0.556, 0.509 0.444, 0.509 0.889, 0.192 0.111, 0.192 0.0737
AD (n=5) 0.074, 0.036 0.926, 0.036 0.688, 0.187 0.312, 0.187 0.96, 0.089 0.04, 0.089 0.0024
AGD (n=5) 0.006, 0.009 0.994, 0.009 0.444, 0.509 0.556, 0.509 0.587, 0.361 0.413, 0.361 0.0693
CBD (n=5) 0.004, 0.006 0.996, 0.006 0.675, 0.395 0.325, 0.395 1, 0 0, 0 0.0061
PiD (n=5) 0.154, 0.118 0.846, 0.118 0.913, 0.092 0.087, 0.092 0.98, 0.045 0.02, 0.045 0.0049
PSP (n=5) 0.008, 0.009 0.992, 0.009 0.927, 0.12 0.073, 0.12 1, 0 0, 0 0.0103
b) Cornu Ammonis 1 Total (n=30) 0.074, 0.171 0.926, 0.171 0.841, 0.25 0.159, 0.25 0.936, 0.149 0.064, 0.149 < 0.0001b
HC (n=5) 0.01, 0.018 0.99, 0.018 0.508, 0.45 0.492, 0.45 1, 0 0, 0 0.0586
AD (n=5) 0.067, 0.102 0.933, 0.102 0.833, 0.078 0.167, 0.078 0.992, 0.017 0.008, 0.017 0.0016
AGD (n=5) 0.001, 0.003 0.999, 0.003 0.917, 0.167 0.083, 0.167 0.833, 0.289 0.167, 0.289 0.0107
CBD (n=5) 0.011, 0.013 0.989, 0.013 1, 0 0, 0 NAc NAc 0.0486
PiD (n=5) 0.345, 0.294 0.655, 0.294 0.965, 0.052 0.035, 0.052 0.894, 0.157 0.106, 0.157 0.0145
PSP (n=5) 0.011, 0.018 0.989, 0.018 0.778, 0.385 0.222, 0.385 1, 0 0, 0 0.0392
c) Superior frontal gyrus Total (n=25) 0.028, 0.038 0.972, 0.038 0.567, 0.395 0.433, 0.395 0.851, 0.357 0.149, 0.357 < 0.0001b
HC (n=5) 0, 0 1, 0 0, 0 1, 0 0, 0 1, 0 NAd
AD (n=5) 0.056, 0.047 0.944, 0.047 0.764, 0.12 0.236, 0.12 0.8, 0.447 0.2, 0.447 0.0365
CBD (n=5) 0.014, 0.013 0.986, 0.013 0.413, 0.433 0.587, 0.433 0.775, 0.437 0.225, 0.437 0.1765
PiD (n=5) 0.065, 0.043 0.935, 0.043 0.816, 0.215 0.184, 0.215 1, 0 0, 0 0.0023
PSP (n=5) 0.005, 0.003 0.995, 0.003 0.625, 0.479 0.375, 0.479 1, 0 0, 0 0.0163
a

p-value computed by a Kruskal-Wallis rank sum test comparing the PHF-1+ proportions in each Rhes phenotype for each disease.

b

p-value for all diseases combined computed using a one-way ANOVA comparing the PHF-1+ proportions in each Rhes phenotype

c

No CA1 neurons with the absent Rhes phenotype were detected in CBD cases

d

The Kruskal-Wallis rank sum test cannot estimate the significant of data lacking variance

Abbreviations: HC, Healthy Controls; AD, Alzheimer’s disease; AGD, Argyrophilic Grain Disease; CBD, Corticobasal Degeneration; PiD, Pick’s disease; PSP, Progressive Supranuclear Palsy